CureVac NV (WBO:CVAC) Change In Inventory : €-47.30 Mil (TTM As of Mar. 2024)

View and export this data going back to 2020. Start your Free Trial

What is CureVac NV Change In Inventory?

CureVac NV's change in inventory for the quarter that ended in Mar. 2024 was €-1.41 Mil. It means CureVac NV's inventory increased by €1.41 Mil from Dec. 2023 to Mar. 2024 .

CureVac NV's change in inventory for the fiscal year that ended in Dec. 2023 was €-47.94 Mil. It means CureVac NV's inventory increased by €47.94 Mil from Dec. 2022 to Dec. 2023 .

CureVac NV's Total Inventories for the quarter that ended in Mar. 2024 was €26.21 Mil.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. CureVac NV's Days Inventory for the quarter that ended in Mar. 2024 was 55.82.

Inventory Turnover measures how fast the company turns over its inventory within a year. CureVac NV's Inventory Turnover for the quarter that ended in Mar. 2024 was 1.63.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. CureVac NV's Inventory-to-Revenue for the quarter that ended in Mar. 2024 was 2.06.

CureVac NV Change In Inventory Historical Data

The historical data trend for CureVac NV's Change In Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CureVac NV Change In Inventory Chart

CureVac NV Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Change In Inventory

Get a 7-Day Free Trial

-3.25

-8.33

-227.46

-47.85

-47.94

CureVac NV Quarterly Data
	Mar19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Change In Inventory	Get a 7-Day Free Trial															-2.05	-3.03	-1.88	-40.97	-1.41

CureVac NV Change In Inventory Calculation

Change In Inventory is the difference between last period's ending inventory and the current period's ending inventory.

Change In Inventory for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €-47.30 Mil.

CureVac NV (WBO:CVAC) Change In Inventory Explanation

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

CureVac NV's Days Inventory for the quarter that ended in is calculated as:

Days Inventory	=	Average Total Inventories	/	Cost of Goods Sold	*	Days in Period
	=	25.504	/	41.689	*	365 / 4
	=	55.82

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

CureVac NV's Inventory Turnover for the quarter that ended in Mar. 2024 is calculated as

Inventory Turnover	=	Cost of Goods Sold	/	Average Total Inventories
	=	41.689	/	25.504
	=	1.63

3. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

CureVac NV's Inventory to Revenue for the quarter that ended in Mar. 2024 is calculated as

Inventory-to-Revenue	=	Average Total Inventories	/	Revenue
	=	25.504	/	12.373
	=	2.06

CureVac NV Change In Inventory Related Terms

Thank you for viewing the detailed overview of CureVac NV's Change In Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.

CureVac NV (WBO:CVAC) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » CureVac NV (WBO:CVAC) » Definitions » Change In Inventory

Comparable Companies

Traded in Other Exchanges

CVAC:USA CVAC:Mexico 1CVAC:Italy 0A9E:UK 5CV:Germany

Address

Friedrich-Miescher-Strasse 15, Tubingen, BW, DEU, 72076

Website

https://www.curevac.com

CureVac is a biopharmaceutical company headquartered in Germany that is developing vaccines and therapies using messenger ribonucleic acid (mRNA). The company was founded in 2000 and had its initial public offering in August 2020. CureVac is collaborating with GlaxoSmithKline to develop a second-generation COVID-19 vaccine. CureVac's first attempt to develop a COVID-19 vaccine did not have sufficient efficacy data, and its trials were discontinued in October 2021. The company's other pipeline candidates include mRNA vaccines for influenza, rabies, and malaria. Additionally, CureVac is in the early stages of development for oncology and molecular therapies spanning tumors, liver, ocular, and lung diseases.